Alectinib shows promise for the treatment of refractory ALK-positive large B-cell lymphoma: a case report

• by Atheer Alsulami, Roula Almufti, Saleem Eldadah, Yahya Al-Ghamdi

• June 17, 2026

Case Report: Pediatric nasopharyngeal carcinoma masquerading as benign lymphadenopathy: diagnostic pitfalls in two cases

• by Yuhan Qiu, Yan Cheng, Aiqin Lin, Hui Li, Jie Liu, Wei Zhang

• June 16, 2026

Parabilis Sets Biotech IPO Record

The clinical-stage cancer biotech raised $670 million in an upsized Nasdaq debut, with a further $75 million expected from a concurrent Regeneron private placement

• June 15, 2026

• 2 min

Case Report: Long-term maternal and neonatal outcomes after nivolumab therapy in metastatic tonsillar sarcomatoid squamous cell carcinoma

• by Elisabetta Guida, Benedetta Apollonio, Chiara Bungaro, Fabio Mele, Sabino Strippoli, Michele Guida

• June 16, 2026